Castle Biosciences, Inc. (CSTL)
20.07
+0.04
(+0.20%)
USD |
NASDAQ |
May 21, 10:12
Castle Biosciences Cash from Investing (Quarterly) : -25.80M for March 31, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Quest Diagnostics, Inc. | -152.00M |
| Labcorp Holdings, Inc. | -322.10M |
| Psychemedics Corp. | -- |
| Fulgent Genetics, Inc. | 10.94M |
| Guardant Health, Inc. | 699.42M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -22.13M |
| Cash from Financing (Quarterly) | -5.033M |
| Free Cash Flow | 4.518M |
| Free Cash Flow Per Share (Quarterly) | -1.157 |
| Free Cash Flow to Equity (Quarterly) | -34.29M |
| Free Cash Flow to Firm (Quarterly) | -34.45M |
| Free Cash Flow Yield | 0.76% |